SMTI

In the past six months, Sanara MedTech's stock price was significantly impacted by the announcement on July 29, 2026, that MiMedx Group, Inc. (MIMEDX) would acquire Sanara MedTech in a cash and stock transaction valued at $35 per share, totaling approximately $350 million, which led to a stock price increase. Other notable events include the company's first-quarter 2026 results on May 12, 2026, where Sanara swung to a profit, causing the stock to rise, and the fourth-quarter 2025 results reported on March 24, 2026. Over the past six months, Sanara MedTech's share price outperformed the S&P500 Index by +43.36%. As of September 23, 2026, the stock price had increased by 6.19% over the last 12 months, with a year-to-date return of 50.54%.